Squeezed by Price Caps And Rising Costs, China's Nepstar Drugstore Chain Pushes Its Own Brands
This article was originally published in PharmAsia News
Executive Summary
Want to get beverages on a drug store run for aspirin in China? Not a problem in Nepstar stores, where China's largest retail pharmacy chain is increasingly becoming more of a convenience store than a traditional drug store. It is shifting its business model to focus on private label products to fend off a double squeeze: swelling rental and labor costs and ongoing governmental reform initiatives to impose price caps on drug retailers
You may also be interested in...
Multinationals Turn To Smaller Markets To Avoid BRIC Restrictions
Poland, Mexico, South Korea and Indonesia all grew between 5% and 6.5% in 2011, and South Africa, Turkey, Vietnam, the “stans” countries and “fascinatingly” Iran, among others, also are likely areas for future expansion of the OTC and self-care market, consultant Nicholas Hall says.
Multinationals Turn To Smaller Markets To Avoid BRIC Restrictions
Poland, Mexico, South Korea and Indonesia all grew between 5% and 6.5% in 2011, and South Africa, Turkey, Vietnam, the “stans” countries and “fascinatingly” Iran, among others, also are likely areas for future expansion of the OTC and self-care market, consultant Nicholas Hall says.
Multinationals Turn To Smaller Markets To Avoid BRIC Restrictions
Poland, Mexico, South Korea and Indonesia all grew between 5% and 6.5% in 2011, and South Africa, Turkey, Vietnam, the “stans” countries and “fascinatingly” Iran, among others, also are likely areas for future expansion of the OTC and self-care market, consultant Nicholas Hall says.